Low prevalence of colonization with vancomycin-resistant enterococcus in patients awaiting liver transplantation

American Journal of Transplantation

Volumn 3, Issue 7, 2003, Pages 902-905

  Hagen, Elisabeth A ^a   Lautenbach, Ebbing ^a   Olthoff, Kim ^a   Blumberg, Emily A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibiotic use; Liver transplantation; VRE

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ADULT; AGED; ALCOHOL LIVER DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PERITONITIS; BACTERIUM CULTURE; CORRELATION ANALYSIS; DRUG USE; ENTEROCOCCUS; FEMALE; HEPATITIS C; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PROSPECTIVE STUDY; RECTUM; RISK FACTOR; SCORING SYSTEM; SCREENING; UNITED STATES;

ADULT; AGED; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; VANCOMYCIN RESISTANCE;

EID: 0038013711     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00169.x     Document Type: Article

References (16)

1. Morris J, Shay D, Hebden J et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 1995; 123: 250-259.
2. Davis J, Huycke M, Wells C et al. Surgical Infection Society position paper on vancomycin-resistant Enterococcus. Arch Surg 1996; 131: 1061-1068.
3. Papanicolaou G, Meyers B, Meyers J et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in transplant recipients: risk factors for acquisition and morbidity. Clin Infect Dis 1996; 23: 760-766.
4. Patel R, Allen S, Manahan J et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001; 7: 27-31.
5. Green M, Barbadora K, Michaels M. Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients. J Clin Micro 1991; 29: 2503-2506.
6. Newell K, Millis J, Arnow P et al. Incidence and outcome of infection by vancomycin-resistant enterococcus following orthotopic liver transplantation. Transplantation 1998; 65: 439-442.
7. Orloff S, Busch A, Olyaei A et al. Vancomycin-resistant enterococcus in liver transplant patients. Am J Surg 1999; 177: 418-422.
8. Donskey C, Chowdry T, Hecker M et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343: 1925-1932.
9. Lautenbach E, Bilker W, Brennan P. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999; 20: 318-323.
10. Ostrowsky B, Trick W, Sohn A et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001; 344: 1427-1433.
11. Tornieporth N, Roberts R, Hafner J, Riley L. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996; 23: 767-772.
12. Rolachon A, Cordier L, Bacq Y, Nousbaum J. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 1995; 22: 1171-1174.
13. Gimes P, Rimola A, Planas R et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo controlled trial. Hepatology 1990; 12: 716-724.
14. Campillo B, Dupeyron C, Richardet J et al. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis 1998; 26: 1066-1070.
15. Kamath P, Wiesner R, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
16. D'Agata E, Gautam S, Green W, Tang Y. Sensitivity of rectal swab for VRE. Clin Infect Dis 2002; 34: 167-172.